TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.

Emmanuel Bachy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.